NEWS CENTER
2017
- Categories:Development path
- Author:济肽生物
- Origin:济肽生物
- Time of issue:2022-01-26 11:41
- Views:0
(Summary description)● The new technology of Biotin-GHK, Hexapeptide-11, Pal-GQPR was successfully developed<br>● The R&D base passed the factory audit of Hyundai IBT, the largest cosmeceutical company in South Korea<br>● The Vitabri cosmetics produced with our company's raw materials is an old luxury brand in the United States Chain store Barneys New York launches
2017
(Summary description)● The new technology of Biotin-GHK, Hexapeptide-11, Pal-GQPR was successfully developed<br>● The R&D base passed the factory audit of Hyundai IBT, the largest cosmeceutical company in South Korea<br>● The Vitabri cosmetics produced with our company's raw materials is an old luxury brand in the United States Chain store Barneys New York launches
- Categories:Development path
- Author:济肽生物
- Origin:济肽生物
- Time of issue:2022-01-26 11:41
- Views:0
● The new technology of Biotin-GHK, Hexapeptide-11, Pal-GQPR was successfully developed<br>● The R&D base passed the factory audit of Hyundai IBT, the largest cosmeceutical company in South Korea<br>● The Vitabri cosmetics produced with our company's raw materials is an old luxury brand in the United States Chain store Barneys New York launches
Scan the QR code to read on your phone
RELATED NEWS
Contact Us
US Headquarters Address: Active Peptide Company
201 River St West Newton, MA 02465 USA.
Address of China Headquarters: No. 22, Jinyu Road, National High-tech Development Zone, Jining City, Shandong Province
Email: info@jitaibiotech.com Web: www.jitaibiotech.com
Copyright(c)2022 All Rights Reserved ICP:2022002432
Contact Us
US Headquarters Address: Active Peptide Company
201 River St West Newton, MA 02465 USA.
Address of China Headquarters: No. 22, Jinyu Road, National High-tech Development Zone, Jining City, Shandong Province,
3rd Floor, East District, Innovation Building
Contact: Mr. Li +86-18660723366
Email: info@jitaibiotech.com
Web: www.jitaibiotech.com
Copyright(c)2022 ICP:2022002432